NTL Pill - orange oval

Pill with imprint NTL is Orange, Oval and has been identified as Lapatinib 250 mg. It is supplied by Lupin Pharmaceuticals, Inc.

Lapatinib is used in the treatment of breast cancer; breast cancer, metastatic and belongs to the drug classes EGFR inhibitors, HER2 inhibitors. There is positive evidence of human fetal risk during pregnancy. Lapatinib 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for NTL

Lapatinib

Imprint

NTL

Strength

250 mg

Color

Orange

Shape

Oval

Availability

Prescription only

Drug Class

EGFR inhibitors, HER2 inhibitors

Pregnancy Category

D - Positive evidence of risk

CSA Schedule

Not a controlled drug

Labeler / Supplier

Lupin Pharmaceuticals, Inc.

Manufacturer

Natco Pharma Limited

National Drug Code (NDC)

68180-0801

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

Related images for "NTL"

Antara

Antara

Thalomid

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer